Author: Heinonen Laura Sandberg Birgitta
Publisher: Palgrave Macmillan Ltd
ISSN: 1478-565X
Source: Journal of Commercial Biotechnology, Vol.14, Iss.4, 2008-10, pp. : 287-298
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Winning the game: Public funds for biotech companies
Journal of Commercial Biotechnology, Vol. 12, Iss. 3, 2006-04 ,pp. :
Can the risks from transgenic crop plants be estimated/
Trends in Biotechnology, Vol. 14, Iss. 12, 1996-12 ,pp. :
Biopharmaceutical production in transgenic livestock
By Rudolph N.S.
Trends in Biotechnology, Vol. 17, Iss. 9, 1999-09 ,pp. :
Heterologous biopharmaceutical protein expression in Streptomyces
By Binnie C. Cossar J.D. Stewart D.I.H.
Trends in Biotechnology, Vol. 15, Iss. 8, 1997-08 ,pp. :